Literature DB >> 2888658

Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.

G Bianchi Porro1, M Lazzaroni, B P Imbimbo, O Sangaletti, C Ghirardosi, S Daniotti.   

Abstract

A study has been done in 10 duodenal ulcer patients of the effect of a single oral dose of 10 mg mifentidine on the acid and pepsin responses to sham feeding after 1 h 30 min and to pentagastrin after 4 h 15 min. The study followed a double-blind, randomized, placebo-controlled, cross-over design. Gastric juice was collected for 5 h 15 min after treatment. Blood was sampled for up to 3 h 30 min to determine the effects of mifentidine on serum gastrin. Mifentidine suppressed basal acid output by 77% and sham feeding-stimulated acid output by 71% vs the placebo values. Pentagastrin-stimulated acid output was inhibited by 30% throughout the pentagastrin infusion. The suppressant effect of the drug on pepsin output was not as marked as on acid secretion. Mifentidine did not affect the serum gastrin level during the basal and sham feeding phases. No untoward effects were reported by the patients. The results show that 10 mg mifentidine p.o. produced a large reduction in the acid output in response to sham feeding and pentagastrin without affecting the serum gastrin responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888658     DOI: 10.1007/bf02455987

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  The use of non-parametric methods in the statistical analysis of the two-period change-over design.

Authors:  G G Koch
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

2.  Plasma gastrin concentrations following sham feeding in duodenal ulcer patients.

Authors:  B Stenquist; G Nilsson; J F Rehfeld; L Olbe
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

3.  Gastric acid response to sham feeding in the duodenal ulcer patient.

Authors:  U Knutson; L Olbe
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

4.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

5.  The analysis of the two-period repeated measurements crossover design with application to clinical trials.

Authors:  S Wallenstein; A C Fisher
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients.

Authors:  S J Konturek; N Kweicień; W Obtułowicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

7.  Gastric secretory and plasma hormonal responses to sham-feeding of varying duration in patients with duodenal ulcer.

Authors:  S J Konturek; J Swierczek; N Kwiecień; W Obtutowicz; M Dobrzańska; B Kopp; J Oleksy
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

8.  Inhibition of acid secretion in dog by metiamide, a histamine antagonist acting on H2 receptors.

Authors:  M I Grossman; S J Konturek
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

9.  Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.

Authors:  C Scarpignato; R Tramacere; M Tangwa; G Bertaccini
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-07

10.  Cephalic phase of gastric secretion in healthy subjects and duodenal ulcer patients: role of vagal innervation.

Authors:  S J Konturek; N Kwiecien; W Obtulowicz; E Mikos; E Sito; J Oleksy; T Popiela
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

View more
  4 in total

1.  Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects.

Authors:  B P Imbimbo; M Seiberling; U Peuckert; G Hoexter; H Maier-Lenz; A Vidi; S Daniotti
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients.

Authors:  G Bianchi Porro; B P Imbimbo; M Lazzaroni
Journal:  Agents Actions       Date:  1988-08

3.  In vitro studies on the metabolic fate of mifentidine, a novel histamine H2-receptor antagonist.

Authors:  K Pattichis; M Kajbaf; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Apr-Jun       Impact factor: 2.441

4.  Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer.

Authors:  F Sabbatini; M Lazzaroni; M Petrillo; G Piai; G Mazzacca; G Bianchi Porro
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.